Literature DB >> 12775743

Groups potentially at risk for making poorly informed decisions about entry into clinical trials for childhood cancer.

Christian Simon1, Stephen J Zyzanski, Michelle Eder, Pauline Raiz, Eric D Kodish, Laura A Siminoff.   

Abstract

PURPOSE: Some patients may be at greater risk than others of enrolling on a randomized clinical trial (RCT) without fully understanding the implications. To investigate this possibility, this study poses the question, Do non-English-speaking Latino parents of children with leukemia show differences in their discussion of and understanding of an RCT when compared with English-speaking minority parents and with English-speaking majority (ie, white) parents? This research hypothesizes that factors such as social and educational status and the role of language interpreters may account for significant differences in the discussion and understanding of an RCT among the three groups. PATIENTS AND METHODS: A total of 108 parents are reported on, all of whom were observed, interviewed, and audiotaped during informed-consent discussions about participation in an RCT with their child's oncologist. Comparisons among the groups were performed using chi2 tests and a one-way analysis of variance.
RESULTS: Problems of consent-related communication and understanding were more frequent among parents of low social status who spoke little or no English than they were in the two other groups. Several factors may have contributed to this disparity, including language interpretation, social status, and prevailing cultural norms.
CONCLUSION: Some patients may be at greater risk than others of enrolling on an RCT without fully understanding the implications of their decision to do so. Numerous factors may contribute to this disparity, including language interpretation, social status, and prevailing cultural norms. Some specific strategies are suggested to help address this disparity.

Entities:  

Mesh:

Year:  2003        PMID: 12775743     DOI: 10.1200/JCO.2003.03.003

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  20 in total

Review 1.  The quality of informed consent: mapping the landscape. A review of empirical data from developing and developed countries.

Authors:  Amulya Mandava; Christine Pace; Benjamin Campbell; Ezekiel Emanuel; Christine Grady
Journal:  J Med Ethics       Date:  2012-02-07       Impact factor: 2.903

2.  Race does not influence do-not-resuscitate status or the number or timing of end-of-life care discussions at a pediatric oncology referral center.

Authors:  Justin N Baker; Shesh Rai; Wei Liu; Kumar Srivastava; Javier R Kane; Christine A Zawistowski; Elizabeth A Burghen; Jami S Gattuso; Nancy West; Jennifer Althoff; Adam Funk; Pamela S Hinds
Journal:  J Palliat Med       Date:  2009-01       Impact factor: 2.947

3.  Participation in pediatric oncology research protocols: Racial/ethnic, language and age-based disparities.

Authors:  Paula Aristizabal; Jenelle Singer; Renee Cooper; Kristen J Wells; Jesse Nodora; Mehrzad Milburn; Sheila Gahagan; Deborah E Schiff; Maria E Martinez
Journal:  Pediatr Blood Cancer       Date:  2015-03-08       Impact factor: 3.167

4.  Understanding of placebo controls among older people with schizophrenia.

Authors:  Laura B Dunn; Barton W Palmer; Monique Keehan
Journal:  Schizophr Bull       Date:  2005-09-21       Impact factor: 9.306

5.  Factors related to voluntary parental decision-making in pediatric oncology.

Authors:  Victoria A Miller; Robert M Nelson
Journal:  Pediatrics       Date:  2012-04-16       Impact factor: 7.124

6.  Parents' views of involvement in concurrent research with their neonates.

Authors:  Frances Rieth Ward
Journal:  J Empir Res Hum Res Ethics       Date:  2010-06       Impact factor: 1.742

7.  Illness severity and parental permission for clinical research in a pediatric ICU population.

Authors:  Jessie M Hulst; Jeroen W B Peters; Ada van den Bos; Koen F M Joosten; Johannes B van Goudoever; Luc J I Zimmermann; Dick Tibboel
Journal:  Intensive Care Med       Date:  2005-05-13       Impact factor: 17.440

8.  Advancing the field of communication research in pediatric oncology: A systematic review of the literature analyzing medical dialogue.

Authors:  Erica C Kaye; Ashley Kiefer; Kristina Zalud; Melanie Gattas; Ian Snyder; Holly Spraker-Perlman; Justin N Baker
Journal:  Pediatr Blood Cancer       Date:  2018-08-01       Impact factor: 3.167

9.  Negotiating decisions during informed consent for pediatric Phase I oncology trials.

Authors:  Patricia A Marshall; Ruth V Magtanong; Angela C Leek; Sabahat Hizlan; Amy D Yamokoski; Eric D Kodish
Journal:  J Empir Res Hum Res Ethics       Date:  2012-04       Impact factor: 1.742

10.  A Qualitative Study of Phase III Cancer Clinical Trial Enrollment Decision-Making: Perspectives from Adolescents, Young Adults, Caregivers, and Providers.

Authors:  Lamia P Barakat; Lisa A Schwartz; Anne Reilly; Janet A Deatrick; Frank Balis
Journal:  J Adolesc Young Adult Oncol       Date:  2014-03-01       Impact factor: 2.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.